Survey regarding clinical and demographic characteristics of Japanese NVAF patient treated with warfarin and physicians treatment strategies to them in general practice.
Not Applicable
- Conditions
- non-valvular artrial fibrillation
- Registration Number
- JPRN-UMIN000024531
- Lead Sponsor
- Pfizer Japan, inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients who are prescribed warfarin for treatment of disease conditions other than for prevention of cardioembolic stroke or systemic embolism. 2)Patients with valvular AF. 3)Patients without definite diagnosis of NVAF 4)Patients whose warfarin treatment is initiated within 52 weeks before the baseline.
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method